| The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV N Hemmat, Z Asadzadeh, NK Ahangar, H Alemohammad, B Najafzadeh, ... Archives of Virology 166, 675-696, 2021 | 81 | 2021 |
| The oncogenic potential of NANOG: An important cancer induction mediator B Najafzadeh, Z Asadzadeh, R Motafakker Azad, A Mokhtarzadeh, ... Journal of cellular physiology 236 (4), 2443-2458, 2021 | 50 | 2021 |
| The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer H Alemohammad, B Najafzadeh, Z Asadzadeh, A Baghbanzadeh, ... Biomedicine & Pharmacotherapy 146, 112516, 2022 | 46 | 2022 |
| Nanog, as a key cancer stem cell marker in tumor progression P Vasefifar, R Motafakkerazad, LA Maleki, S Najafi, F Ghrobaninezhad, ... Gene 827, 146448, 2022 | 43 | 2022 |
| Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction H Alemohammad, Z Asadzadeh, N Hemmat, B Najafzadeh, P Vasefifar, ... Life Sciences 260, 118337, 2020 | 16 | 2020 |
| Tumor necrosis factor‑α in systemic lupus erythematosus: Structure, function and therapeutic implications F Ghorbaninezhad, P Leone, H Alemohammad, B Najafzadeh, ... International Journal of Molecular Medicine 49 (4), 1-13, 2022 | 15 | 2022 |
| Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy? F Ghorbaninezhad, H Alemohammad, B Najafzadeh, J Masoumi, ... Cancer Letters, 216168, 2023 | 12 | 2023 |
| siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin H Alemohammad, R Motafakkerazad, Z Asadzadeh, N Farsad, N Hemmat, ... Gene 821, 146333, 2022 | 7 | 2022 |
| Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration B Najafzadeh, R Motafakkerazad, S Najafi, M Amini, H Alemohammad, ... Pathology-Research and Practice 233, 153869, 2022 | 2 | 2022 |
| Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells P Vasefifar, S Najafi, R Motafakkerazad, M Amini, S Safaei, B Najafzadeh, ... Experimental Cell Research 429 (2), 113681, 2023 | 1 | 2023 |
| Restoration of miR-200c sensitizes breast cancer cells to cytarabine MM Moghaddam, E Baghbani, H Alizadeh, B Najafzadeh, T Kazemi, ... | | 2023 |
behzad baradaranImmunology Research Center, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir
